Top Markets
#1 DogBull DogBull +106.37%
#2 ADO Protocol ADO Protocol +51.14%
#3 Siacoin Siacoin +50.69%
#4 The Bitcoin Bull The Bitcoin Bull +44.16%
#5 MarsCoin MarsCoin +36.63%
#6 龙虾 (Lobster) 龙虾 (Lobster) +30.76%
#7 Glidr Glidr +27.02%
#8 Ontology Gas Ontology Gas +23.03%
#9 UnifAI Network UnifAI Network +19.91%
#10 Falcon Finance Falcon Finance +17.55%
Coin of the day
DogBull DogBull
सेटिंग्स
भाषा
हिन्दी
मुद्रा
USD
थीम
Jiangsu Recbio Technology Co., Ltd. Jiangsu Recbio Technology Co., Ltd.

Jiangsu Recbio Technology Co., Ltd.

2179
शेयरों में रैंक #15657
Jiangsu Recbio Technology Co., Ltd. operates as a biotechnology company... Jiangsu Recbio Technology Co., Ltd. operates as a biotechnology company primarily engaged in the pioneering research, development, and eventual market introduction of subunit vaccines throughout the People's Republic of China. A significant portion of its pipeline is dedicated to combating human papillomavirus (HPV)-related diseases, including cervical cancer and genital warts. Its most advanced candidate, REC603, is a recombinant 9-valent HPV vaccine currently undergoing Phase III clinical trials. Additionally, two bivalent HPV vaccines, REC601 and REC602, are progressing through Phase I trials. Further early-stage development includes the quadrivalent REC604a and 9-valent REC604b recombinant HPV vaccines, both in preclinical stages. Beyond HPV, the company boasts a diverse pipeline addressing other infectious diseases. Its COVID-19 efforts include ReCOV, a recombinant vaccine candidate in Phase II/III trials, and the preclinical messenger RNA (mRNA) candidate, R520A. Other preclinical projects target various conditions, such as the recombinant shingles vaccine REC610, the virus-vectored adult tuberculosis vaccine REC607, and its recombinant counterpart REC606. Also in preclinical development are the recombinant quadrivalent influenza vaccine REC617 and the recombinant quadrivalent hand-foot-mouth disease vaccine REC605. Established in 2011, Recbio Technology maintains its headquarters in Taizhou, People's Republic of China.
शेयर मूल्य
$0.63963115
अंतिम समन्वयन: 2026-08-26
मार्केट कैप
$339.16M
बदलाव (1 दिन)
0.00%
बदलाव (1 वर्ष)
-35.23%
देश
CN
व्यापार Jiangsu Recbio Technology Co., Ltd. (2179)

श्रेणी

Healthcare
Jiangsu Recbio Technology Co., Ltd. (2179) के लिए स्टॉक मूल्य इतिहास
दिन का सबसे उच्च समापन मूल्य: $0.64 (2026-08-01 को)

दिन का सबसे निम्न समापन मूल्य: $3.22 (2022-03-01 को)
Jiangsu Recbio Technology Co., Ltd. के स्टॉक मूल्य का इतिहास 2022 से 2026 तक
प्रत्येक वर्ष के अंत में स्टॉक मूल्य प्रदर्शन
वर्ष प्रदर्शन
2026 (TTM) 4.07%
2025 -37.60%
2024 -16.16%
2023 -55.93%
2022 0.00%
समान कंपनियों या प्रतिस्पर्धियों के स्टॉक मूल्य
कंपनी स्टॉक मूल्य परिवर्तन 1व% देश
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $550.06 40.67%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 44.03%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $150.50 524.74%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.37 -11.93%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $748.60 4.92%
CH